Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

GE Healthcare highlights molecular imaging technologies to help clinicians improve patient experiences

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Lumizyme receives FDA approval for patients with late-onset Pompe disease

Report underscores need for additional research on diagnosis and treatment of food allergy

Report underscores need for additional research on diagnosis and treatment of food allergy

No clear consensus on prevalence, diagnosis, management, and prevention of food allergies

No clear consensus on prevalence, diagnosis, management, and prevention of food allergies

FAAN conference provides new insights about food allergies and anaphylaxis

FAAN conference provides new insights about food allergies and anaphylaxis

Plant-based system could help improve lives of hemophilic patients

Plant-based system could help improve lives of hemophilic patients

Campbell Soup honored for commitment to food allergy safety, awareness and education

Campbell Soup honored for commitment to food allergy safety, awareness and education

Children with severe food allergic reactions need two doses of epinephrine

Children with severe food allergic reactions need two doses of epinephrine

Shock: Norepinephrine favored over dopamine

Shock: Norepinephrine favored over dopamine

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

Data demonstrating effectiveness of KALBITOR to treat acute HAE presented at AAAAI 2010 Annual Meeting

New book on baking recipes for people with food allergies

New book on baking recipes for people with food allergies

Sciele Pharma announces the U.S. availability of Adrenaclick

Sciele Pharma announces the U.S. availability of Adrenaclick

Knowledge gaps exist among physicians in diagnosis and management of food allergy

Knowledge gaps exist among physicians in diagnosis and management of food allergy

New guidelines on the management of antithrombotic agents for endoscopic procedures published

New guidelines on the management of antithrombotic agents for endoscopic procedures published

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

GSK updates long-term survival data of BEXXAR Therapeutic Regimen for Non-Hodgkin's lymphoma

Kalbitor drug approved by FDA

Kalbitor drug approved by FDA

FDA grants approval for Dyax' KALBITOR for treating HAE patients

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Sanofi-Aventis Canada and Intelliject sign license agreement

Sanofi-Aventis Canada and Intelliject sign license agreement

Intelliject announces an exclusive license with sanofi-aventis for epinephrine auto-injector

Intelliject announces an exclusive license with sanofi-aventis for epinephrine auto-injector

Sanofi-aventis, Intelliject sign an exclusive licensing agreement for novel epinephrine auto injector

Sanofi-aventis, Intelliject sign an exclusive licensing agreement for novel epinephrine auto injector